CVE Intelligence
Critical Injection

CVE-2025-30050 — Remote Code Execution in CGM CLININET

CGM CLININET is vulnerable to Code Injection in the RunCGI.pm component, which dynamically imports the module specified as a query parameter and executes code from untrusted data provided by the user. An attacker from adjacent network can supply a crafted query parameter to have an attacker-controlled module imported which results in arbitrary code execution with root privileges. This issue was fixed in version 2026.MS3

Published Oct 23, 2026 · Updated Oct 28, 2026 · Sources: NIST National Vulnerability Database, CVE Program (cve.org) e CISA ADP, GitHub Security Advisories · CNA: CERT-PL

Who exploits it and how urgent it is

A 0–100 score combining confirmed exploitation, ransomware and APT use, public exploits, EPSS and severity.

No exploitation signal in the sources consulted so far.
How the score was calculated
  • EPSS 0.2% (30-day exploitation probability)+2
  • Technical severity (critical)+10

The score orders the patch queue; it does not replace your asset context (internet exposure, criticality, compensating controls).

Triage

Is it exploited, how likely is exploitation, what does it touch, and how severe do the sources call it.

Exploitation
Not confirmed
Not in CISA KEV — an absence of record, not proof it is unexploited.
EPSS FIRST
0.22%
ahead of 13% of scored CVEs · Oct 30, 2026
Affects
CGM
Clininet
CVSS base
9.4
Critical · 2 source(s)

CISA SSVC assessment CISA

Three decision points CISA publishes for the CVEs it assesses (SSVC 2.0.3). A stakeholder decision, not a severity score.

Exploitation
None
none · proof-of-concept · active
Automatable
No
can an attacker script the kill-chain steps
Technical impact
Total
partial · total control of the vulnerable component

Remediation

Fixes and mitigations documented by the sources — linked to the original advisory.

No fix documented by the sources we poll. That does not mean none exists: check the vendor advisory.

First 24 hours

Ordered from the record’s own fields — exposure first, because you cannot patch what you have not found. A rule-generated starting point.

  1. Identify exposed assets running the affected vendor/product/version combinations (CGM Clininet).
  2. No fix documented in the sources: reduce exposure and monitor the vendor advisory.
  3. Search available logs for exploit probes matching the vulnerability class (injection), errors and authentication anomalies.

Affected scope

Vendor, product and versions as the sources word them.

VendorProductVersionsStatusSource
CGM Clininet < 2026.MS3 Vulnerable CVE Program (cve.org) e CISA ADP

Attack characteristics

The CVSS vector, decoded. It describes the attack, not your exposure to it.

Attack vector
Adjacent
Attack complexity
Low
Attack requirements
None
Privileges required
None
User interaction
None
Scope
X
Confidentiality (vulnerable system)
High
Integrity (vulnerable system)
High
Availability (vulnerable system)
High
Confidentiality (subsequent)
High
Integrity (subsequent)
High
Availability (subsequent)
High

Every base score collected

Sources score independently and may disagree; each row says who scored it and under which version.

ScoreVersionSeverityExpl.ImpactScored by
9.4 CVSS 4.0 Critical — — cvd@cert.pl via NIST National Vulnerability Database
9.4 CVSS 4.0 Critical — — CERT-PL via CVE Program (cve.org) e CISA ADP
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X (score shown at the top: cvd@cert.pl)

Weakness MITRE

Weakness class according to MITRE’s CWE catalog.

CWE-94 · Code Injection

Other CVEs with this weakness →

EPSS over time FIRST

Oct 23, 2026 → Oct 30, 2026 · 8 reading(s) · max 0.22%

Detection

Read off the CVSS vector and the weakness class. Starting points, not tested rules.

  • Look for parameters with command/query metacharacters and unexpected child processes of the service.
application logsendpoint telemetry (EDR)

Timeline

What happened to this CVE, newest first.

  • 2026
  • SSVC assessment updated
    Oct 28, 2026 · CVE Program (cve.org) e CISA ADP
  • Source status changed · Received → Deferred
    Oct 23, 2026 · NIST National Vulnerability Database
  • Affected products added · cgm/cgm clininet
    Oct 23, 2026 · CVE Program (cve.org) e CISA ADP
  • Record published
    Oct 23, 2026
  • CVSS changed · 9.4
    Oct 23, 2026 · NIST National Vulnerability Database
  • Source status changed · → Received
    Oct 23, 2026 · NIST National Vulnerability Database
  • Record created in this database
    Oct 23, 2026 · Alertas do Telegram
  • CVE published
    Oct 23, 2026 · CERT-PL

Source activity

Repeated readings are counted rather than listed.

  • 2× References added · Oct 23, 2026 – Oct 28, 2026
  • 1× Official description updated · Oct 23, 2026 – Oct 23, 2026

References

5 on the record

Elsewhere on this site

CGM
every CVE for this vendor
Injection
same class
CWE-94
other pages naming this weakness

Related CVEs (same products)

  • CVE-2025-58403 Reflected Cross-Site Scripting (XSS) in CGM CLININET 8d
  • CVE-2025-30052 Authentication Bypass via IP Spoofing in CGM CLININET rsyncd 8d
  • CVE-2025-30053 Missing Authentication in CGM CLININET 8d
  • CVE-2025-30054 Local Privilege Escalation in CGM CLININET 8d
  • CVE-2025-30047 Remote Code Execution via Java Deserialization in CGM CLININET 8d
  • CVE-2025-30049 Use of Unsalted MD5 Password Hashes in CGM CLININET 8d

Not in any source we poll

Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.

  • No fixed version, patch or mitigation documented.
  • No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
  • No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
  • No exploit packet captures, log samples, or incident case IDs supplied.

Answered from this record

Text assembled only from the fields above — no additional claims.

What should defenders know first?

CVE-2025-30050 is "Remote Code Execution in CGM CLININET", rated Critical. It affects Clininet (CGM); versions are in the scope table. It is not in CISA KEV, which does not rule out exploitation. CVSS 9.4 describes technical severity. EPSS 0.22% estimates the probability of exploitation in 30 days; neither replaces your asset context. First verify whether exposed or business-critical assets run the affected versions, apply vendor fixes or mitigations, and preserve logs for review.

Comments

Moderated technical discussion. Read the community guidelines.

No comments yet.

Sign in or create an account to comment and suggest corrections.